Clinical

Dataset Information

0

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation


ABSTRACT: This is Phase Ib/II, multicenter, open-label adaptive platform study of JDQ443 with select therapies in patients with advanced solid tumors harboring the KRAS G12C mutation.

DISEASE(S): Colorectal Tumors,Carcinoma, Non-small Cell Lung,Carcinoma,Malignant Solid Tumor,Kras G12c Mutant Solid Tumors,Colorectal Cancer,Advanced Solid Tumors,Lung Neoplasms,Neoplasms,Nonsmall Cell Lung Cancer,Colorectal Carcinoma,Neoplasms, Colorectal,Kras Mutation,Nsclc,Non-small Cell Lung Cancer,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung,Non-small Cell Lung Carcinoma,Adult Patients With Advanced (metastatic Or Unresectable) Kras G12c Mutant Solid Tumors

PROVIDER: 2726548 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2020-07-01 | GSE134586 | GEO
2020-10-01 | GSE149815 | GEO
| 2386408 | ecrin-mdr-crc
| 2309880 | ecrin-mdr-crc
| 2743980 | ecrin-mdr-crc
| 2331996 | ecrin-mdr-crc
2023-09-11 | GSE240110 | GEO
2023-09-11 | GSE240118 | GEO
2023-09-11 | GSE240113 | GEO
2022-08-24 | GSE199582 | GEO